Top broker names 2 of the best ASX share ideas for November

These two ASX shares are highly rated…

| More on:
A businessman lights up the fifth star in a lineup, indicating positive share price for a top performer

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for a few new additions to your portfolio in November, then look no further.

Analysts at Morgans have picked out a number of ASX shares that they class as their best ideas for the month.

Below are two top ASX shares that the broker rates highly this month. They are as follows:

BHP Group Ltd (ASX: BHP)

Morgans is a fan of this mining giant for a number of reasons. This includes its valuation, strong balance sheet, and dividend profile. It also sees BHP as a low risk option in the resources sector for investors.

It explained: "We view BHP as relatively low risk given its superior diversification relative to its major global mining peers. The spread of BHP's operations also supplies some defence against direct COVID-19 impact on earnings contributors. While there are more leveraged plays sensitive to a global recovery scenario, we see BHP as holding an attractive combination of upside sensitivity, balance sheet strength and resilient dividend profile."

Morgans currently has an add rating and $46.05 price target on BHP's shares. This compares to the current BHP share price of $35.65.

ResMed Inc (ASX: RMD)

Another ASX share for investors to consider is ResMed. Morgans is a fan of this sleep treatment focused medical device company due partly to its positive long term outlook.

Morgans commented: "While we believe the next few quarters will likely be volatile, as COVID-related demand for ventilators continues to slow and core sleep apnoea volumes gradually lift, nothing changes our medium/longer term view that the company remains well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain."

Its analysts have an add rating and $40.80 price target on the company's shares. This compares to the latest ResMed share price of $35.22.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Happy man holding Australian dollar notes, representing dividends.
Broker Notes

Why this cheap ASX All Ords stock could rise 50% and pay an 11% dividend yield

Goldman Sachs thinks that big returns could be coming for buyers of this stock.

Read more »

Woman using a pen on a digital stock market chart in an office.
Broker Notes

CSL stock: Buy, hold, or sell in 2025?

Let's see what analysts are saying about this blue chip giant at the start of the year.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Goldman Sachs says this ASX 200 stock is a top buy in January

The broker is forecasting some big returns for investors this year.

Read more »

A man working in the stock exchange.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys right now.

Read more »

A group of businesspeople clapping.
Broker Notes

2 of the best ASX 200 shares to buy in the Asia-Pacific

Goldman Sachs is speaking very highly about these stocks this month.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Broker Notes

4 ASX 200 shares just upgraded for 2025 by top brokers

Leading brokers are forecasting strong performance in 2025 from these four ASX 200 companies.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Broker Notes

This beaten down ASX 200 stock could rise 90%

Bell Potter thinks this stock could be dirt cheap after a recent selloff.

Read more »

Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these stocks.

Read more »